D. Mike Steelman, Nacd.Dc Email & Phone Number

I develop the strategy and tactics necessary to simplify access to Dexcom technology through partnerships with payors and other channel customers. This includes leading and developing the team accountable for representing Dexcom products to the payor community on a national and regional level (government, health plans, PBMs, employers, etc.).

Boca Raton, Florida

After years with 2 Big Pharma companies, I joined this innovative, small-cap, women’s health pharmaceutical company in its early growth phase. I was promoted from market-access VP to CCO in 2021 to manage all external customer-facing revenue efforts. I managed a cross-functional team of 4 direct/141indirect reports across sales, market access, trade, strategic partnerships, and advocacy. My priority is driving strategic change in the customer-relationship model and spurring explosive growth. Previously, as market-access VP, I established a talented market-access team, infrastructure, and a start-up public health business. Additionally, I created all the payor strategies, pricing, contracts and SOPs.Key Priorities & Successes:► Currently executing efforts to turn 8-figures in net revenue into 9-figures by 2022 through team unification, in addition to creating a customer-centric culture and counter impact of COVID-19 on revenue growth.► As market-access VP, made immediate impact, leading team of 13 that encompassed all market access areas, translating to: - Net revenue skyrocketing $44M in 2 years to generate $60M. - Payor access secured for 3 newly launched FDA-approved products in 18 mos. - Unrestricted commercial access for new products launched: 70% (ANNOVERA) and 75% (BIJUVA and IMVEXXY). - Gross-to-net improvement through direct, strategic-partnership agreements with top-tier pharma retailers. - Awards: Cardinal Health Supply Chain Excellence/McKesson Brand Vendor of the Year/HEB Pharmacy Supplier of the Year.

Bridgewater, New Jersey, United States

I was promoted to VP in 2016 to oversee strategic and operational global pricing (specialty/rare diseases, vaccines, diabetes/cardiovascular, and general medicines). I spearheaded a major initiative to ensure robust price performance, converting decentralized pricing efforts across 4 business units into 1 unified team with cohesive pricing strategy, SOPs, and single global-pricing system. Additionally, I oversaw 30 professionals and a 11-figure product portfolio consisting of 40 products in 100 countries.Key Priorities & Successes:► Directed 2 company-firsts, establishing public declaration of pricing principles, making Sanofi one of the first companies to provide transparency through pricing clarity. Also introduced global-pricing governance enterprise-wide, decreasing risk by instituting policies for pricing decisions, rebates, and reporting while aligning distribution rates.► Ensured smooth transition. collaborating with team and business-unit heads to gain valuable feedback and buy-in on pricing to guide key planning and decisions. Also presented to board.►Established launch pricing of 7 products worldwide and managed post-launch changes for entire $35B product portfolio.►Launched Dupixent, generating 10-figures in sales, 2019. Led to media attention, with Forbes article. ► Worked cross-functionally, including with finance, legal, sales, and marketing areas, on topics that range from product pricing and changes to complex contracts and ensuring everyone is on the same page.

Bridgewater, New Jersey, United States

I was recruited by a former direct-manager at Pfizer to serve as an internal thought leader on market access, and together with my team, created the company’s first market access competency framework, program, and materials, enabling worldwide alignment and greatly enhanced team effectiveness. Also provided emergency support to teams (pricing, HEOR, V&A strategists). Key Priorities & Successes:► Achieved favorable program-value ratings of 3.37/4 for standardized, in-depth market-access training program to develop talent of 750-person global market-access community through capability-driven strategies. Set uniform standards across U.S. and globally. ► Developed program in-house and oversaw delivery of 128 training sessions, positively impacting 2,300+ employees while eliminating costly consulting fees. ► Expanded training to nonmarket-access areas, from HR, legal, finance, country managers, and spokespeople, to educate on market access worldwide and ensure consistent message.► Served as market-access expert and major contributor with 12 peers (competitors) to set common standards and definition framework for industry-based access competencies. Article published in Pharmaceutical Executive, Nov. 2016.

Greater New York City Area

Overall tenure at Pfizer: I gained broad experience and was promoted 6x over my long-term tenure at this Fortune 50 pharmaceutical company with $50B+ in annual revenue. I advanced from the front-line to senior director roles and provided a fresh and strategic perspective in sales, market access and marketing, leading to innovative strategies/initiatives and robust results.irAs the academy lead, I provided leadership to drive talent development across market-access groups, with priority focus on strategies to strengthen talent, engagement, and effectiveness. I facilitated sharing of best practices at the global level by introducing and managing strategies and resources. Key Priorities & Successes:–►Impacted employees across the lifecycle and improved employee retention through robust onboarding and training programs as well as a career-progression platform.►Developed Pfizer’s first worldwide, customized, market-access training program, impacting 500 market access employees.

Greater New York City Area

I was recruited internally by the head of Pfizer’s U.S. business to spearhead market access within LATAM market, a strategic high-growth opportunity. I defined the strategy and hired and developed a highly talented, performance-driven market-access team of ~55 direct/ indirect reports. Key Priorities & Successes:► Became trusted advisor to Pfizer’s LATAM regional president for market access. ► Provided executive oversight to guide team in mitigating impact of international reference-pricing by $15M.► Positioned region for growth, including $2M in Brazil, by creating LATAM Regional Tenders Committee.► Expanded previously limited market-access presence in the region, moving at rapid speed to start up region, from operational governance to building team of 53, including 9 country leads.► Oversaw pricing decisions that translated to $980M in revenue as well as developed annual plan to respond to market-access issues, established pricing governance, assessed quality of pricing-strategy proposals, quantified regional P&L impact from policy changes. and approved country market-access plans.

Greater New York City Area

In 2012, I was promoted to this senior director role from my previous strategy lead (managed-markets) position for primary care marketing with $4B in U.S. brands. I led a new, centralized national account team to further penetrate the government market and develop access strategies for $3B+ in revenue, such as GPOs and federal programs. Key Priorities & Successes:► Proposed/directed 4 major growth initiatives, including quality access framework, aligning company for first time with payor contracting strategy across sales, marketing, and market access. Also spearheaded national account team that led Medicaid expansion after passing of ACA as well as generated $8M through strategic inventory management.

Greater New York City Area

Identified revenue-maximizers and cost drivers, such as new CEO-endorsed pricing strategy that spurred $200M revenue boost in declining market for Celebrex, leading to Top U.S. Marketing “Vanguard” award. Eliminated low-value accounts that saved total of $3M in rebate spend and crafted industry-leading cost and coverage message, leading to 6%TRx increase.

Managed $35M in sales volume. Multi-award winner while growing high-value accounts: MCOs, Medicaid, DoD, coalitions, and employers. Product access: 20+ major wins.

Led $128M district and team of 10. Improved ranking from 65th to 15th. Recognized as Most Valuable Manager within region.

Ranked in top 5% (of 105) and earned multiple awards.

Managed a 15 person team which synthesized, analyzed and provided competitor insights to the Commanding General and staff of a 10,000 person organization. Served as Information Security Officer.

M.S., Pharmacy, Public Policy, And Pharmacoeconomics

Public Policy and Health Outcomes

Mba, Business

M.S., Human Resources Administration

B.S., Geography, Geology

Activities and Societies: Delta Sigma Phi

Cert Certificate In Cyber Security Oversight